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Hypertensive disorders of pregnancy (HDP) are the commonest 
medical complication in pregnancy, and remain the commonest 
direct cause of maternal mortality in South Africa.1 The latest (2005 - 
2007) Saving Mothers report (SMR) indicates that there were 622 
maternal deaths from HDP during this period, virtually the same as 
in the 2002 - 2004 report.1,2 Numbers of deaths reported in the two 
previous SMRs were 507 for 1999 - 20013 and 628 for 2002 - 2004;2 
these differences probably indicate under-reporting in the triennium 
1999 - 2001. The most recent reports, 2002 - 20042 and 2005 - 2007,1 
better reflect the numbers of maternal deaths from HDP.
Maternal deaths in South Africa are notifiable to the Department 
of Health (DoH) and are reported in a structured ‘Maternal death 
notification form’, which contains demographic data and clinical 
details surrounding the primary and secondary causes of death. 
This form, together with a copy of the hospital records, is sent to the 
provincial Maternal, Women and Child Cluster, which has trained 
assessors (an experienced maternal health specialist and a midwife) 
to formulate a confidential opinion on any sub-standard care 
based on patient-related, administrative and health personnel-related 
factors. Assessments are collated every 3 years and published as the 
SMR, which includes recommendations to reduce maternal deaths.
Causes of hypertensive maternal 
deaths in South Africa
Table I shows the primary causes of deaths in the sub-categories of 
hypertensive disorders that are similar to the 2002 - 2004 report.2 
Eclampsia accounted for 55.3% (N=344) of the deaths in the period 
2005 - 2007 and cerebral complications for 283 (45.5%). Other causes 
of deaths included multi-organ failure, cardiac failure, metabolic 
complications and disseminated intravascular coagulation.
Demographic data
Of the 344 women who died from eclampsia, 171 were younger than 
24 years, and of these 83 were below the age of 20 years; 50 were above 
the age of 35 years. Most women who died from eclampsia were also 
of low parity; 182 were primigravidas and 129 were of parity 1 - 3. 
Timing of the emergency event
A large proportion of deaths occurred in the postpartum period. 
Most of these women had their convulsions in the antenatal period 
(N=322); 20 had their first convulsion in the postpartum period 
either in hospital, or at home after discharge from hospital.
Avoidable factors (N=344)
Patient avoidable factors were mainly related to delay in seeking help 
and infrequent attendance for antenatal care; 180 (60%) of the 344 
women who died had attended an antenatal clinic.
The major administrative factors were delay in transport between 
institutions (11%) and communication problems between institutions 
and in institutions (11%). Others included delay in transport from 
home to institution, barrier to entry, lack of accessibility, lack of 
health personnel, and lack of appropriately trained staff. 
Health care provider avoidable factors in 336 assessable 
deaths related mainly to delay in referring patients (N=63; 18%); 
management at an inappropriate level of health care facility (N=73; 
21%); substandard care but correct diagnosis (N=106; 31%); failure to 
diagnose (N=68; 20%); and infrequent monitoring (N=27; 8%). 
Clinical features of severe pre-eclampsia are often not taken 
into account by inexperienced health personnel. In our current 
understanding of the causation of pre-eclampsia, delivery of the 
fetus and placenta leads to cure. Since these women are still at risk 
of complications from the disease process in the period immediately 
after delivery, continued frequent observations of the pulse rate, blood 
pressure, urinary output, level of consciousness and potential signs 
of pulmonary oedema must be ensured. Antihypertensive therapy 
must be continued and should not be stopped abruptly. Magnesium 
sulphate (MgSO4) should be continued for at least 24 hours after 
delivery. All laboratory tests must be repeated within 4 - 6 hours after 
delivery and results reviewed. Patients should not be discharged until 
their blood pressure levels have been stable for a period of at least 24 
hours. Furthermore, they should be asked to return to the postnatal 
clinic of the hospital within a week and only referred to a community 
clinic when all physical and laboratory tests have returned to normal 
(this should have taken place within 7 days of delivery). Advice on 
contraception, further pregnancies and the place (level of health care 
facility) of future antenatal  care  should be provided.
Discussion
Eclampsia is the commonest direct cause of maternal death in South 
Africa, which is of concern since it is preventable if pre-eclampsia 
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Table I.  Primary obstetric causes of death in the sub- 
categories
 2005 - 2007 2002 - 2004
Sub-categories N % N %
Chronic hypertension 38 6.1 37 5.9
Proteinuric hypertension 173 27.8 171 27.2
Eclampsia 344 55.3 347 55.3
HELLP syndrome 54 8.7 70 11.1
Rupture of the liver 10 1.6 3 0.5
Acute fatty liver 3 0.48 0 0.0
   Total 622 628
HELLP = haemolysis, elevated liver enzyme levels and a low platelet count.
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is detected early and managed by early delivery. In under-resourced 
countries, the availability of MgSO4 and the lack of protocols 
of management are significant issues associated with maternal 
deaths due to pre-eclampsia.4,5 In South Africa these factors should 
not be issues, as MgSO4 is widely available and on the essential 
drugs list for level 1 health facilities (district hospitals and clinics). 
Clinical guidelines for management of HDP, and in particular the 
management of obstetric emergencies,6,7 have been widely distributed 
to all hospitals and clinics, but are perhaps not reaching all health 
professionals. Regular face-to-face teaching and emergency drills on 
the labour ward floor may improve the situation.
Intracranial haemorrhage remains the commonest final cause of 
death in HDP. Although the exact mechanisms that cause hypertension 
and intracranial haemorrhage are not clearly understood, it appears 
that systolic and diastolic hypertension play a role. It is generally 
accepted that diastolic blood pressures of ≥110 mmHg are linked 
with intracranial pathology, but recently systolic hypertension has 
also been found to play a significant role. A systolic blood pressure 
value above which urgent antihypertensive treatment should be given 
has been identified as 155 - 160 mmHg.8  The latest Why Women Die 
publication (2003 - 2005) recommends that ‘women with a systolic 
blood pressure of >160 mmHg need antihypertensive treatment. 
Consideration should also be given to initiating antihypertensive 
treatment at lower blood pressure values if the overall clinical 
picture suggests rapid deterioration with anticipation of severe 
hypertension.’9 
In this audit, among the 207 women who had cerebral complications, 
the average blood pressures were systolic 177 mmHg (range 103 - 244) 
and diastolic 115 (range 74 - 162).  These extremely high systolic and 
diastolic blood pressures imply that young women with severe pre-
eclampsia and eclampsia require rapid but smooth lowering of high 
blood pressure. This is particularly important as most of the patients 
are young with an abrupt onset of hypertension. Eighty per cent of 
207 women who had convulsions were primigravidas, and their mean 
age was 27 years (range 13 - 45); 16 had systolic blood pressures of 
>160 mmHg with diastolic blood pressures of less than 110 mmHg. 
High blood pressure is of extreme importance and must be lowered 
rapidly, and blood pressure should be measured frequently during the 
acute phase.10 Although contentious, attention should also be given to 
the use of benzodiazepines to arrest seizures. It is likely that the blood 
pressures rise further during seizures and that most cerebrovascular 
accidents occur at this time, particularly in patients with low platelet 
counts.  In South Africa, oral nifedipine, dihydralazine and labetalol 
are used for this purpose.7,8,11
In the 2005 - 2007 SMR, cardiac failure (32.8%) and renal failure 
(10.3%) were assigned as the final and contributory causes of maternal 
deaths (Tables I and II).1 The number of deaths due to renal failure 
has declined in the 2005 - 2007 report, but those from cardiac failure 
have increased since the 2002 - 2004 report. In the hospital records of 
the patients it is difficult to distinguish between death from cardiac 
failure and fluid overload from renal failure because cardiac failure 
might lead to hypotension or pulmonary oedema or both; respiratory 
failure also carries the inference of tachypnoea, which may develop for 
many reasons, including pulmonary oedema. It is likely that all these 
terms may indicate deaths due to pulmonary oedema. It is of concern 
that the number of deaths from cardiac failure (probably pulmonary 
oedema) have increased in the 2005 - 2007 SMR, particularly when 
guidelines on fluid balance are available.2 In the latest UK report 
(Why Women Die) there were no deaths from pulmonary causes 
alone, an improvement probably due to the availability of good fluid 
management clinical protocols.9 
In a report on maternal deaths related to hypertension, one of 
27 deaths between 2000 and 2004 was due to cardiac failure. The 
authors point out that obstetricians should be aware that postpartum 
mobilisation of extracellular water and subsequent shift into the 
intravascular compartment can aggravate hypertension.11
Fluid overload should be recognised early and treated adequately. 
Detecting patients at risk by history and examination, early referral 
and appropriate critical care is therefore essential for patients with 
severe pre-eclampsia.
Infrequent antenatal attendance remains a challenge. In South 
Africa’s public hospitals most women ‘book’ for antenatal care, but 
often after the 22nd week of pregnancy, and attend infrequently. 
The last report emphasised community education on the benefits of 
antenatal care, but this appears not to have been implemented. Public 
health education and involvement of partners and families should 
again be a priority.
 In the previous report2 the issue of ‘hidden pregnancies’ was 
highlighted. In this report many young women died from eclampsia; 
specifically, 3 teenagers aged 13, 14 and 15 years had ‘hidden 
pregnancies’, so there was considerable delay in seeking help. 
Education, provision of contraception and family support are key 
factors in preventing teenage pregnancies. 
Maternity care is free of charge in South Africa and access to 
antenatal clinics widely available, so other social and cultural factors 
may be causing pregnant teenagers not to attend antenatal clinics. 
Improvement in education and dissemination of health information 
on radio, television and the print media may help to overcome this 
challenge. More specifically, education of antenatal attendees at time 
of booking and at every visit should be emphasised. Women with 
chronic hypertension or those with pre-eclampsia being treated as 
outpatients should be informed about the likely complications and 
steps to take if these symptoms occur.
The previous report2 also highlighted problems related to 
emergency management and recommendations were made regarding 
undergraduate, postgraduate and continuing professional education, 
including that all doctors should undergo a course on emergency 
Table II. Final and contributory causes of maternal deaths 
for hypertension and a comparison with 2005 - 2007 and 
2002 - 2004
2005 - 2007 2002 - 2004
Organ system N % N %
Hypovolaemic shock 50 8.0 49 7.8
Septic shock 20 3.2 16 2.5
Respiratory failure 158 25.4 155 24.7
Cardiac failure 142 22.8 89 14.2
Renal failure 64 10.3 88 14.8
Liver failure 30 4.8 31 4.9
Cerebral complications 283 45.5 316 50.3
Metabolic complications 26 4.2 7 1.1
DIC 70 11.3 89 14.2
Multi-organ failure 88 14.1 104 16.6
Immune system failure 31 5.0 18 2.9
Unknown 56 9.0 56 8.9
 DIC = disseminated intravascular coagulation.
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resuscitation before registering as general practitioners; hands-
on courses on mannequins done at frequent intervals are also 
recommended. The National Committee on Confidential Enquiries 
into Maternal Deaths is promoting essential steps in the management 
of obstetric emergencies (ESMOE). This involves trainers visiting all 
health districts and carrying out training on mannequins and other 
visual aids on the emergency management of common conditions 
causing maternal deaths. 
Previous SMRs have not identified cases of acute fatty liver of 
pregnancy (AFLP), but there is an impression that this condition 
does occasionally occur.2,3 Whether these deaths should be grouped 
under HDP is debatable. AFLP is defined as a condition that 
occurs abruptly in the second half of pregnancy and presents 
with increasing jaundice and right upper quadrant pain. The liver 
enzymes (transaminases) are abnormal and patients go on to develop 
coagulopathy and encephalopathy. Treatment involves supportive 
measures and delivery of the fetus. On pathological examination the 
liver shows fatty changes in the hepatocytes.12 
There were 3 cases of maternal death grouped under AFLP. All 
took place at the same tertiary hospital and its geographical drainage 
area, all the patients were relatively young (26 - 30 years), parity 2 
and in the second half of pregnancy, and all presented with jaundice 
and abdominal pain. One had mild hypertension, 2 had autopsies 
in keeping with fatty changes in the liver, and the third was said to 
have had all the clinical features of AFLP. As they were all from the 
same geographical area, the questions of viral infections, drug-related 
effects, or heavy alcohol intake are raised.
Conclusion
The majority of maternal deaths from hypertensive disorders in 
South Africa are associated with avoidable factors and substandard 
care. The challenge is to implement the recommendations arising 
from the SMRs. There is evidence from the 2005 - 2005 report that 
maternal deaths due to hypertension are decreasing, but more effort 
needs to be put into increasing the skills of health care professionals 
and  improving the information on maternity care that we provide to 
women, fathers, families and  communities.
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Gastro-intestinal cytomegalovirus (CMV) infection manifests as 
oesophagitis, gastritis, enteritis and colitis.1,2 Reports of duodenal 
involvement are rare.3 We found only one reported CMV-induced 
pseudotumour of the duodenum and 14 CMV-induced gastro-
intestinal pseudotumours.4-6
Case report
A 35-year-old woman presented with cholestatic jaundice and 
partial bowel obstruction following 3 months’ history of intermittent 
abdominal pain, nausea and vomiting. She had been diagnosed HIV 
positive 2 years before presentation, and had had no further follow- 
up. An abdominal ultrasound scan demonstrated splenic micro-
abscesses, mesenteric and para-aortic lymphadenopathy and an 
indiscrete mass in the region of the head of the pancreas. A computed 
tomography (CT) scan (Fig. 1) confirmed a mass inseparable from 
the first part of the duodenum (D1) in the region of the head of 
the pancreas, compressing the common bile duct (CBD). Magnetic 
resonance cholangiopancreatography (MRCP) (Fig. 2) demonstrated 
dilated intrahepatic ducts and a long distal CBD stricture. Empiric 
tuberculosis (TB) treatment was started in view of the intra-
abdominal lymph nodes, splenic micro-abscesses and pancreatic 
mass, with poor clinical response.
Because of the patient’s poor clinical response to TB treatment 
gastroscopy was performed, and an exophytic lesion at the second 
part of the duodenum (D2) was encountered which the scope was 
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